The Enforcement Directorate has initiated a probe under the Prevention of Money Laundering Act (PMLA) into what is alleged to be a large-scale fraud embedded in the procurement pipeline of government hospitals, according to a report by The indian Express. The alleged scale — Rs 350 crore — places it among the larger medical procurement cases the agency has pursued.

As of publication, The indian Express report does not specify the exact date the case was registered, the state or city where the alleged fraud occurred, the specific hospitals involved, or the identities of any accused. The predicate offence — the underlying FIR or complaint on which the ED's PMLA case is based — has also not been publicly identified. india Herald has not been able to independently verify details beyond those reported by The indian Express, and the ED has not issued a public statement on the matter at the time of writing.

No accused individuals or entities have been publicly named in connection with the case. india Herald was unable to identify or reach any parties for comment. government procurement authorities connected to the case have not been identified in available reporting. This article will be updated if and when responses are received or further details emerge.

How Procurement Fraud Typically Operates, According to Investigators and Auditors

While the specifics of the Rs 350 crore case are not yet public, the Comptroller and Auditor General (CAG) has repeatedly flagged systemic vulnerabilities in government medical procurement. According to multiple CAG audit reports on state health departments — including reports tabled in parliament — recurring issues include tender specifications allegedly tailored to favour particular vendors, competitive bidders locked out through technical disqualifications, and contracts awarded to firms with minimal verifiable infrastructure.

To illustrate the kind of price inflation that auditors have documented: CAG reports on state health procurement have found instances where equipment was purchased at multiples of prevailing market rates. For example, a 2022 CAG report on a state health mission flagged medical equipment purchased at rates significantly above reference prices established by the government's own rate contracts. These are illustrative of documented patterns, not specific allegations in the current ED case.

In the laundering phase, according to patterns established in previous PMLA prosecution complaints reviewed by courts, inflated payments are typically routed through chains of intermediary entities. Each transfer adds a layer of apparent legitimacy. The ED's task under PMLA is to trace this chain — to establish that the proceeds of the predicate offence were knowingly laundered.

Why Medical Procurement Has Been Flagged as Structurally Vulnerable

Defence procurement attracts parliamentary committee scrutiny. Infrastructure spending invites dedicated CAG performance audits. Medical procurement in state-run hospitals, by contrast, has been identified by oversight bodies as operating with comparatively weaker monitoring. Several structural factors, documented in CAG and niti aayog assessments, contribute:

Urgency-based exceptions: Hospitals cannot wait — emergency purchase provisions allow officials to bypass standard tendering protocols. A 2021 CAG audit of COVID-era procurement across multiple states found that emergency provisions, intended as exceptions, were used as the default procurement mode in a significant proportion of purchases.

Technical opacity: Unlike infrastructure projects where physical progress is visible, medical equipment quality requires specialised assessment. This information asymmetry has been identified by the Central Vigilance Commission (CVC) as a risk factor in procurement fraud.

Fragmentation: Procurement is often decentralised across hundreds of district hospitals and primary health centres, each with its own purchasing authority. niti aayog has noted the absence of centralised price-tracking dashboards in many states, which makes cross-facility rate comparison difficult.

The ED's PMLA Powers — and Their Structural Limits

The Enforcement Directorate operates under the Prevention of Money Laundering Act, 2002, which provides powers including provisional attachment of property, arrest in certain circumstances, and — once a prima facie case is established — a reversal of the burden of proof. In procurement fraud cases, the ED typically enters after a predicate offence has been registered by state police, an economic offences wing, or the CBI.

According to The indian Express report, the Rs 350 crore case follows this established pattern. The ED's PMLA probe will run parallel to whatever criminal investigation is underway, with the specific mandate of identifying, attaching, and ultimately seeking confiscation of the alleged proceeds of crime.

It is important to note, however, that the ED's mandate covers the money trail — not the structural reform of procurement processes. Previous medical procurement fraud investigations in various indian states have resulted in arrests and property attachments, but public policy experts have noted that the procurement ecosystem itself has seen limited systemic reform. The same structural vulnerabilities — urgency exceptions, technical opacity, fragmented oversight — persist across states, according to assessments by bodies including the CVC and CAG.

What the Enforcement Directorate Is

For readers unfamiliar with the agency: the ED is a law enforcement body under the Union Ministry of Finance's Department of Revenue. It enforces two key statutes — the PMLA and the Foreign Exchange Management Act (FEMA). Unlike the CBI, which investigates the underlying crime, the ED's jurisdiction is specifically over the financial trail. It is headed by a director and its operational footprint spans zonal offices across India. The agency requires a scheduled predicate offence — such as cheating, fraud, or corruption — to have been registered by another agency before it can initiate a PMLA case.

Scale in Context

Rs 350 crore is the alleged scale as reported by The indian Express. The investigation is at a preliminary stage, and the final determination of the amount involved, if any, will be made through the legal process. For context, according to Union Budget documents, the Ministry of health and Family Welfare's allocation for 2025-26 is approximately Rs 99,000 crore (as per Budget Estimates tabled in Parliament). The alleged amount in this single case, if established, would represent a significant sum relative to overall health spending — though any systemic extrapolation from a single case would be speculative at this stage.

What is not speculative is the pattern identified by India's own audit and oversight institutions: medical procurement, as currently structured in many states, carries documented risks of price inflation, vendor capture, and inadequate post-purchase verification. Whether the Rs 350 crore case proves to be an isolated instance or part of a wider pattern is a question the investigation — and the courts — will answer.

This is a developing story. india Herald will update this article as further details emerge from the ED, law enforcement agencies, or court proceedings. All allegations are as reported and remain unproven until adjudicated.